Mcinnesi Risankizumab News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mcinnesi Risankizumab. Real-time updates on events, politics, business and more.

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

November 8, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it would present new data across its rheumatology portfolio, including RINVOQ® (upadacitinib) for...

United States Mcinnesi Risankizumab Celine Goldberger Boehringer Ingelheim American College Of Rheumatology Exchange Commission

Source: prnewswire.com

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

November 8, 2022

Thirty-six abstracts underscore AbbVies commitment to advancing research to help more people living with rheumatic diseasesAdditional analysis of...

United States Mcinnesi Risankizumab Celine Goldberger Boehringer Ingelheim American College Of Rheumatology Exchange Commission

Source: businessinsider.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Mcinnesi Risankizumab News Today

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022

Explore More Categories